Results 71 to 80 of about 7,331 (198)
Physiological Reports, Volume 14, Issue 12, June 2026.Abstract Obstructive sleep apnea (OSA) with an apnea‐hypopnea index (AHI) ≥ 15/h increases the cardiovascular disease (CVD) risk in type 1 diabetes (T1D). Cardiovascular autonomic neuropathy (CAN) is a key driver of CVD in diabetes and could be increased by autonomic nervous system (ANS) dysfunction related to OSA.
Marion Faivre +10 more
wiley +1 more source
Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
Indian Heart Journal, 2018 Background: Heart rate (HR) reduction is of benefit in chronic heart failure (HF). The effect of heart rate reduction using Ivabradine on various echocardiographic parameters in dilated cardiomyopathy has been less investigated.
Deep Chandh Raja +8 more
doaj +1 more source
Clinical utility of ivabradine in cardiovascular disease management: current status
, 2014 Giuseppe MC Rosano,1,2 Cristiana Vitale,1,2 Ilaria Spoletini,1 Maurizio Volterrani11Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy; 2Cardiovascular and Cell Sciences Research Institute, St George's University of London, London,
Volterrani M +3 more
core
Quality of life with ivabradine in patients with angina pectoris [PDF]
, 2016 Background—To explore the effect of ivabradine on angina-related quality of life (QoL) in patients participating in the Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients with Coronary Artery Disease (SIGNIFY) QoL
Steg, Philippe Gabriel +7 more
core +1 more source
Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry
Clinical Cardiology, Volume 49, Issue 5, May 2026.ABSTRACT Aims The Türkiye Heart Failure (TURK‐HF) registry aims to identify the sociodemographic and clinical characteristics, management strategies, and outcomes of patients with heart failure (HF) and to assess the implementation of evidence‐based HF therapies in Türkiye.
Umut Kocabas +46 more
wiley +1 more source
A TRIP‐nano killer silencing the pain pacemakers
The Journal of Physiology, EarlyView.
Elisabetta Cerbai
wiley +1 more source
Structure mirroring function: What's the ‘matter’ with the funny current?
The Journal of Physiology, Volume 604, Issue 9, Page 3513-3532, 1 May 2026.Abstract figure legend The ‘funny’ (If) current of cardiac pacemaker cells has been first identified in the late 1970s as a major mechanism in the generation and control of cardiac pacemaking. Decades of studies have since described the properties of the funny current and of its molecular components, HCN channels, in the heart and brain, providing the ...
Andrea Saponaro, Dario DiFrancesco
wiley +1 more source
Advances in the management of heart failure: the role of ivabradine
, 2016 Ursula Müller-Werdan,1,2 Georg Stöckl,3 Karl Werdan4 1Charité – Universitätsmedizin Berlin, 2Protestant Geriatric Centre, Berlin, 3Department of Medical Affairs, Servier Deutschland GmbH, Munich, 4Department of Medicine ...
Müller-Werdan U, Stöckl G, Werdan K
core
Inotropic Effects of Ivabradine in the Mammalian Heart
, 2010 Ivabradine represents a novel heart-rate-lowering agent that acts on the sino-atrial node supposedly by selectively inhibiting the ‘funny’ current (I<sub>f</sub> current).
Klaus Pönicke +5 more
core +1 more source
The Thoracic Lymphatic Vasculature: Interorgan Strategies to Achieve an Optimal Tissue Function
Comprehensive Physiology, Volume 16, Issue 2, April 2026.In the thorax, organ‐specific features such as stomata and submesothelial lacunae, pulmonary perivascular and peribronchial vessels, and subepicardial lymphatic network allow the thoracic lymphatics to perform as a dynamically regulated system able to exploit local mechanical forces and tissue‐specific architecture to maintain fluid and solute ...
Daniela Negrini +3 more
wiley +1 more source